NYSE: ABBV · Drug Manufacturers - General
Over the past week, Abbvie (ABBV) pulled in about 176 mentions across Reddit, X and news, and the read is an Adanos Sell. The crowd averages 32% bullish but is at odds: X runs 42% bullish while Reddit sits at just 16%. Wall Street is more constructive, with 24 of 31 analysts rating ABBV a buy.
There is steady buzz around ABBV this week and little agreement on direction, which is why it reads as a Sell.
Wall Street’s 77% buy share sits next to a crowd that ranges from Reddit at 16% to X at 42%. No other tracker puts the two side by side.
31 analysts have weighed in: a Strong Buy consensus: 24 buy calls against 1 sell, with an average 12-month price target of $276.59.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is improving and the 3 sources only partly agree, so the read is a Sell.
Analysts sit 45 points above the crowd average of 32%, the professionals are more constructive than retail. The split is inside the crowd: X reads 42% bullish while Reddit sits at 16%, a 26-point spread that single-source trackers miss.
Weekly price context: this Alpha Vantage chart keeps its own dated range; the sentiment metrics elsewhere on this page may be newer. Over the 30-day window, Abbvie (ABBV) buzz held subdued around 36.4 while the price drifted up 1.8% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 4.9M shares. Updated Aug 29, 2026. Over the last 7 trading days, ABBV lost 2.4%. Buzz activity in the recent week averaged 42.7 and was relatively stable, swinging between 36.4 and 52.6. Recent volume is in line with the 30-day average, reflecting steady institutional and retail participation. Daily crowd sentiment leaned bullish on 18 of the 21 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for ABBV and 2001+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live ABBV sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Aug 30, 2026.
| Adanos signal | Sell |
|---|---|
| Analyst consensus | Strong Buy (24 / 6 / 1) |
| Crowd bullish (7d) | 32% |
| Avg price target | $276.59 |
| Most bullish source | X, 42% |
| Most bearish source | Reddit, 16% |
| Sentiment spread | 26 pts |
| Mentions (7d) | 176 |
| Market cap | $456.18B |
| P/E · Forward P/E | 74.0 · 18.7 |
| EPS · Beta | $3.49 · 0.3 |
| Revenue (TTM) | $64.39B · 10% margin |
| Industry | Drug Manufacturers - General |
Based on aggregated sentiment from Reddit, X and News sources, Abbvie (ABBV) currently carries an Adanos sell signal with 93/100 conviction. The current cross-source average reads 32% bullish across 3 active sources. Those sources contribute 176 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Abbvie (ABBV) is fairly quiet with 19 mentions over the last 7 days; the 30-day context spans 15 tracked subreddits. The 7-day tone is 16% bullish; 3-day activity momentum is stable, suggesting steady attention.
The crowd reads bearish on Abbvie (ABBV), averaging 32% bullish across 3 tracked sources over the last 7 days. The two ends of the range are X at 42% bullish and Reddit at 16%, a 26-point spread. On the professional side, 24 of 31 analysts rate ABBV a buy.
Of the 31 analysts covering Abbvie (ABBV), 24 rate it a buy, 6 a hold and 1 a sell, for a strong buy consensus. The average price target is $276.59. That puts the street ahead of the crowd, which averages 32% bullish.
Abbvie (ABBV)'s cross-source average is bearish at 32% bullish. All 3 tracked sources lean bearish. X reads 42% bullish, News reads 39% bullish and reddit coverage is the most negative at 16% bullish. The combined signal points to broad sell-side pressure with 93/100 conviction.
The cross-source average is bearish for Abbvie (ABBV) at 32% bullish. All 3 tracked sources lean bearish. The most bearish reading is reddit at 16% bullish. 3-day activity momentum is rising across X and News. The sell signal carries 93/100 conviction.
X is the dominant discussion channel with 96 mentions (55% of total volume). News contributes 61 mentions and Reddit contributes 19 mentions. The cross-source average is bearish at 32% bullish, while x and news show rising 3-day activity. All 3 tracked sources lean bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. ABBV's sell signal at 93/100 conviction reflects a bearish cross-source average at 32% bullish. All 3 tracked sources lean bearish. It is a research shortcut, not financial advice.
The ABBV sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Sell signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key